Patrick Serruys

Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations

Lunardi M, Louvard Y, Lefèvre T, Stankovic G, Burzotta F, Kassab G, Lassen J, Darremont O, Garg S, Koo B, Holm N, Johnson TW, Pan M, Chatzizisis YS, Banning AP, Chieffo A, Dudek D, Hildick-Smith D, Garot J, Henry T, Dangas G, Stone G, Krucoff M, Cutlip D, Mehran R, Wijns W, Sharif F, Serruys P, Onuma Y

May 18, 2022 | 10.4244/EIJ-E-22-00018

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hara H, Kawashima H, Ono M, Takahashi K, Mack M, Holmes D, Morice M, Davierwala P, Mohr F, Thuijs D, Kappetein AP, O'Leary N, van Klaveren D, Onuma Y, Serruys P

April 22, 2022 | 10.4244/EIJ-D-21-00415

A comparison of risk prediction models for patients with acute coronary syndromes

Hara H, O'Leary N, Ono M, Onuma Y, Serruys P

March 18, 2022 | 10.4244/EIJ-D-21-00536

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter R, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits P, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys P

March 15, 2022 | 10.4244/EIJ-D-21-00766

Ticagrelor or aspirin 1 year after revascularisation: a landmark analysis of the GLOBAL LEADERS trial

Ono M, Hara H, Kawashima H, Gao C, Wang R, Wykrzykowska J, Piek J, Garg S, Hamm C, Steg P, Valgimigli M, Windecker S, Vranckx P, Onuma Y, Serruys P

March 9, 2022 | 10.4244/EIJ-D-21-00870

EuroIntervention: the 200th issue

Serruys P

January 28, 2022 | 10.4244/EIJ-E-21-00004

Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown WM, Serruys P, Kappetein AP, Sabik J, Stone G

January 28, 2022 | 10.4244/EIJ-D-21-00338

Reply: Composite endpoints in clinical trials - simplicity or perfection?

Hara H, Onuma Y, Serruys P

January 28, 2022 | 10.4244/EIJ-D-21-00440R

Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials

Azzalini L, Ellis S, Kereiakes D, Kimura T, Gao R, Onuma Y, Chevalier B, Dressler O, Crowley A, Zhou Z, Redfors B, Serruys P, Stone G

December 17, 2021 | 10.4244/EIJ-D-21-00263

Chronic haemodynamic performance of a biorestorative transcatheter heart valve in an ovine model

Serruys P, Kawashima H, Chang C, Modolo R, Wang R, de Winter R, Van Hauwermeiren H, El-Kurdi M, van den Bergh W, Cox M, Onuma Y, Flameng W, Soliman O

December 17, 2021 | 10.4244/EIJ-D-21-00386

Understanding the past, getting prepared for the future. (Going from in vivo to in vitro to in silico)

Serruys P, Elkoumy A, Soliman O

November 19, 2021 | 10.4244/EIJV17I10A136

Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial

Faria D, Lee J, van de Hoef T, Mejía-Rentería H, Echavarria-Pinto M, Baptista S, Cerrato E, Garcia-Garcia H, Davies J, Onuma Y, Samady H, Piek J, Serruys P, Lerman A, Escaned J

October 20, 2021 | 10.4244/EIJ-D-20-01163

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein AP, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Statistical methods for composite endpoints

Hara H, van Klaveren D, Kogame N, Chichareon P, Modolo R, Tomaniak M, Ono M, Kawashima H, Takahashi K, Capodanno D, Onuma Y, Serruys P

April 2, 2021 | 10.4244/EIJ-D-19-00953

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van de Hoef T

April 2, 2021 | 10.4244/EIJ-D-19-00774

Five-year clinical outcomes of zotarolimus-eluting stents in coronary total occlusions

Kelbæk H, Yeh R, Engstrøm T, Neumann F, Serruys P, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S

March 19, 2021 | 10.4244/EIJ-D-19-00866

Online three-dimensional OFDI-guided versus angiography-guided PCI in bifurcation lesions: design and rationale of the randomised OPTIMUM trial

Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y

March 19, 2021 | 10.4244/EIJ-D-18-00902

Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study

Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P

February 19, 2021 | 10.4244/EIJ-D-18-01201

Coronary interventions in 2020: the year in review

Lunardi M, Gao C, Hara H, Ono M, Kawashima H, Wang R, Wijns W, Serruys P, Onuma Y

February 5, 2021 | 10.4244/EIJ-D-20-01343

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein AP, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Patrick Serruys

Latest news